Photodynamic therapy of idiopathic subfoveal choroidal neovascularization in Taiwanese patients: A 2-year follow-up

Eye

Volumn 23, Issue 2, 2009, Pages 314-319

  Chen, Y S ^a   Lin, J Y S ^b   Tseng, S Y ^a   Tang, H F ^c   Lee, H J ^a   Lin, Y R ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Choroidal neovascularization; Photodynamic therapy; Taiwan; Verteporfin

Indexed keywords

VERTEPORFIN; PHOTOSENSITIZING AGENT; PORPHYRIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; CHOROID DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EYE; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; MALE; PHOTODYNAMIC THERAPY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SUBRETINAL NEOVASCULARIZATION; TAIWAN; VISION; VISUAL ACUITY; ADOLESCENT; AGE; CHOROIDAL NEOVASCULARIZATION; COMPARATIVE STUDY; EVALUATION STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROGNOSIS; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 60149099023     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6703073     Document Type: Article

References (23)

1. Fukuchi T, Takahashi K, Ida H, Sho K, Matsumura M. Staging of idiopathic choroidal neovascularization by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2001; 239: 424-429.
2. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996; 103: 1241-1244.
3. Giansanti F, Virgili G, Varano M, Tedeschi M, Rapizzi E, Giacomelli G et al. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina 2005; 25: 590-596.
4. Chan WM, Lam DS, Wong TH, Lai TY, Kwok AK, Tam BS et al. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series. Ophthalmology 2003; 110: 2395-2402.
5. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch Ophthalmol 1999; 117: 1329-1345.
6. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993; 111: 1200-1209.
7. Verteporfin Roundtable Participants. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 2005; 25: 119-134.
8. Stone TW, Sternberg Jr P. Submacular surgery trials update. Ophthalmol Clin North Am 2002; 15: 479-488.
9. Ruiz-Moreno JM, Montero JA, Arias L, Sanabria MR, Coco R, Silva R et al. Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization. Acta Ophthalmol Scand 2006; 84: 743-748.
10. Kumar A, Prakas G, Singh RP. Transpupillary thermotherapy for idiopathic subfoveal choroidal neovascularization. Acta Ophthalmol Scand 2004; 82: 205-208.
11. Yoo MH, Boo HD, Kim HK. Result of photodynamic therapy for idiopathic subfoveal choroidal neovascularization. Korean J Ophthalmol 2005; 19: 264-268.
12. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: 2-year results of 2 randomized clinical trials - TAP report 2. Arch Ophthalmol 2001; 119: 198-207.
13. Lam A, Lee HC, Ho AC, Regillo CD, McNamara JA, Fineman MD. Photodynamic therapy in young patients. Ophthalmic Surg Lasers Imaging 2006; 37: 182-189.
14. Fenton C, Perry CM. Verteporfin: a review of its use in the management of subfoveal choroidal neovascularisation. Drugs Aging 2006; 23: 421-445.
15. Chan WM, Lai TY, Tano Y, Liu DT, Li KK, Lam DS. Photodynamic therapy of macular diseases of Asian populations: when East meets West. Jpn J Ophthalmol 2006; 50: 161-169.
16. Maár N, Ergun E, Luksch A, Stur M. Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1262-1266.
17. Chen YS, Lin JY, Tseng SY, Yow SG, Hsu WJ, Tsai SC. Photodynamic therapy for Taiwanese patients with pathologic myopia: a 2-year follow-up. Retina 2007; 27(7): 839-845.
18. Capone Jr A, Wallace RT, Meredith TA. Symptomatic choroidal neovascularization in blacks. Arch Ophthalmol 1994; 112: 1091-1097.
19. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 2003; 110(5): 979-986.
20. Ergun E, Heinzl H, Stur M. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 2004; 138: 434-438.
21. Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y et al. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment. Am J Ophthalmol 2004; 138: 602-607.
22. Ho AC, Yannuzzi LA, Pisicano K, DeRosa J. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology 1995; 102: 782-789.
23. Rogers AH, Duker JS, Nichols N, Baker BJ. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003; 110: 1315-1320.